Variant report

Variant	esv2763361
Chromosome Location	chr4:55102425-55107618
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:11)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:11 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr4:55102485-55102857	IMR90	lung:	n/a	n/a
2	CTCF	chr4:55102320-55102470	GM12868	blood:	n/a	n/a
3	FOS	chr4:55102536-55102762	MCF10A-Er-Src	breast:	n/a	n/a
4	KAP1	chr4:55107321-55107674	HEK293	kidney:	n/a	n/a
5	KAP1	chr4:55107376-55107676	U2OS	brain:	n/a	n/a
6	POLR2A	chr4:55107085-55107268	MCF10A-Er-Src	breast:	n/a	n/a
7	POLR2A	chr4:55107473-55107630	MCF10A-Er-Src	breast:	n/a	n/a
8	POLR2A	chr4:55103649-55103712	H1-hESC	embryonic stem cell:	n/a	n/a
9	SETDB1	chr4:55107016-55108210	U2OS	brain:	n/a	n/a
10	ZNF143	chr4:55104091-55104275	K562	blood:	n/a	n/a
11	ZNF143	chr4:55107434-55107714	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:55104084-55104134	ProgFib	skin:	n/a
2	chr4:55104084-55104134	GM12892	blood:	n/a
3	chr4:55104084-55104134	A549	lung:	n/a
4	chr4:55104084-55104134	ovcar-3	ovarian:	n/a
5	chr4:55104084-55104134	IMR90	lung:	fetal
6	chr4:55104084-55104134	SK-N-MC	brain:	n/a
7	chr4:55104084-55104134	MCF10A-Er-Src	breast:	n/a
8	chr4:55104084-55104134	BJ	skin:	n/a
9	chr4:55104084-55104134	HRCEpiC	kidney:	n/a
10	chr4:55104084-55104134	SAEC	small airway:	n/a
11	chr4:55104084-55104134	NHDF-neo	bronchial:	n/a
12	chr4:55104084-55104134	Hela-S3	cervix:	n/a
13	chr4:55104084-55104134	HCT-116	colon:	n/a
14	chr4:55104084-55104134	GM06990	blood:	n/a
15	chr4:55104084-55104134	NB4	blood:	n/a
16	chr4:55104084-55104134	T-47D	breast:	n/a
17	chr4:55104084-55104134	HAEpiC	amniotic membrane:	n/a
18	chr4:55104084-55104134	Jurkat	blood:	n/a
19	chr4:55104084-55104134	SKMC	muscle:	n/a
20	chr4:55104084-55104134	HNPCEpiC	eye:	n/a
21	chr4:55104084-55104134	HL-60	blood:	n/a
22	chr4:55104084-55104134	AG04450	lung:	fetal
23	chr4:55104084-55104134	PANC-1	pancreas:	n/a
24	chr4:55104084-55104134	HMEC	breast:	n/a
25	chr4:55104084-55104134	NHBE	bronchial:	n/a
26	chr4:55104084-55104134	HRE	kidney:	n/a
27	chr4:55104084-55104134	SK-N-SH	brain:	n/a
28	chr4:55104084-55104134	Caco-2	colon:	n/a
29	chr4:55104084-55104134	GM19239	blood:	n/a
30	chr4:55104084-55104134	NT2-D1	testis:	n/a
31	chr4:55104084-55104134	MCF-7	breast:	n/a
32	chr4:55104084-55104134	AoSMC	blood vessel:	n/a
33	chr4:55104084-55104134	AG04449	skin:	fetal
34	chr4:55104084-55104134	U87	brain:	n/a
35	chr4:55104084-55104134	HEEpiC	esophagus:	n/a
36	chr4:55104084-55104134	SK-N-SH_RA	brain:	n/a
37	chr4:55104084-55104134	RPTEC	kidney:	n/a
38	chr4:55104084-55104134	HCM	heart:	n/a
39	chr4:55104084-55104134	ECC-1	luminal epithelium:	n/a
40	chr4:55104084-55104134	HUVEC	blood vessel:	n/a
41	chr4:55104084-55104134	Hepatocyte	liver:	n/a
42	chr4:55104084-55104134	HPAEpiC	pulmonary alveolar:	n/a
43	chr4:55104084-55104134	BE2_C	brain:	n/a
44	chr4:55104084-55104134	HCF	heart:	n/a
45	chr4:55104084-55104134	HepG2	liver:	n/a
46	chr4:55104084-55104134	HEK293	kidney:	embryo
47	chr4:55104084-55104134	LNCaP	prostate:	n/a
48	chr4:55104084-55104134	CMK	blood:	n/a
49	chr4:55104084-55104134	GM12878	blood:	n/a
50	chr4:55104084-55104134	HIPEpiC	eye:	n/a

No data

Variant related genes	Relation type
PDGFRA	TF binding region
PDGFRA	CpG island

Extended variants
information (count: 188 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:188 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7678144	chr4:55102425-55102426	Strong transcription Genic enhancers Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs75680560	chr4:55102430-55102431	Strong transcription Genic enhancers Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
3	rs555549436	chr4:55102466-55102467	Strong transcription Genic enhancers Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
4	rs545316347	chr4:55102537-55102538	Strong transcription Genic enhancers Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
5	rs6554163	chr4:55102559-55102560	Strong transcription Genic enhancers Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs112591060	chr4:55102603-55102604	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs370272256	chr4:55102661-55102662	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs375317580	chr4:55102669-55102670	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs111280965	chr4:55102689-55102690	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs557696185	chr4:55102720-55102721	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs577954809	chr4:55102736-55102737	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs6836215	chr4:55102741-55102742	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs566937904	chr4:55102755-55102756	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs184810908	chr4:55102814-55102815	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs113973896	chr4:55102822-55102823	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs576301430	chr4:55102862-55102863	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs542007299	chr4:55102885-55102886	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs561869632	chr4:55102895-55102896	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs527809399	chr4:55102948-55102949	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs552378796	chr4:55102978-55102979	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs527355257	chr4:55103045-55103046	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs190131555	chr4:55103058-55103059	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs564194627	chr4:55103069-55103070	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs552783122	chr4:55103073-55103074	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs571092824	chr4:55103088-55103089	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs111896235	chr4:55103106-55103107	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs569659745	chr4:55103110-55103111	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs532936205	chr4:55103111-55103112	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs372482703	chr4:55103147-55103148	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs75586168	chr4:55103153-55103154	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs74965721	chr4:55103154-55103155	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs538527289	chr4:55103168-55103169	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs556531265	chr4:55103170-55103171	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs535776162	chr4:55103196-55103197	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs549136568	chr4:55103218-55103219	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs565948662	chr4:55103259-55103260	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs568744549	chr4:55103261-55103262	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs552945685	chr4:55103303-55103304	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs557808620	chr4:55103377-55103378	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs142078001	chr4:55103388-55103389	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs552092312	chr4:55103396-55103397	Strong transcription Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs571856424	chr4:55103411-55103412	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs534355868	chr4:55103429-55103430	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs181585053	chr4:55103432-55103433	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs535072485	chr4:55103433-55103434	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs78941306	chr4:55103556-55103557	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs561833414	chr4:55103570-55103571	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs553370544	chr4:55103586-55103587	ZNF genes & repeats Genic enhancers Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs572244035	chr4:55103603-55103604	ZNF genes & repeats Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs541271997	chr4:55103607-55103608	ZNF genes & repeats Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	19435819	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian neoplasms	16753589	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Glioblastoma multiforme	21569311	CNVD
Glioblastoma	17504929	CNVD
Glioblastoma	16823502	CNVD
Melanoma	16908931	CNVD
Glioblastoma	20031968	CNVD
Medulloblastoma	19270706	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Olfactory neuroblastoma	18408657	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Rhabdomyosarcoma	16790082	CNVD
Gastrointestinal stromal cancer	17438095	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	19208797	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	19115005	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21138945	CNVD
Cancer	20164920	CNVD
Rhabdomyosarcoma	20807811	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:108 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:55100600-55104400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
2	chr4:55101000-55103800	Weak transcription	Colonic Mucosa	Colon
3	chr4:55101000-55104200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr4:55101000-55104400	Weak transcription	HMEC	breast
5	chr4:55101000-55105200	Weak transcription	Aorta	Aorta
6	chr4:55101200-55105800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr4:55101200-55106400	Weak transcription	Right Atrium	heart
8	chr4:55101400-55102600	Enhancers	Osteobl	bone
9	chr4:55101400-55103000	Weak transcription	Cortex derived primary cultured neurospheres	brain
10	chr4:55101400-55103200	Weak transcription	Fetal Stomach	stomach
11	chr4:55101400-55104000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr4:55101400-55104600	Weak transcription	Colon Smooth Muscle	Colon
13	chr4:55101400-55110200	Weak transcription	Fetal Kidney	kidney
14	chr4:55101600-55102600	Transcr. at gene 5' and 3'	NHLF	lung
15	chr4:55101600-55103400	Strong transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
16	chr4:55102000-55102600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr4:55102000-55102600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr4:55102000-55102600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
19	chr4:55102000-55102600	Flanking Active TSS	Ovary	ovary
20	chr4:55102000-55102600	Enhancers	NHDF-Ad	bronchial
21	chr4:55102000-55102800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr4:55102200-55103000	Weak transcription	Fetal Lung	lung
23	chr4:55102200-55105200	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr4:55102400-55102600	Bivalent Enhancer	Stomach Smooth Muscle	stomach
25	chr4:55102400-55102800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr4:55102400-55102800	Weak transcription	Placenta	Placenta
27	chr4:55102400-55103400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr4:55102400-55103800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr4:55102600-55103400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
30	chr4:55102600-55103400	Weak transcription	NHLF	lung
31	chr4:55102600-55103600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr4:55102600-55103600	Weak transcription	Osteobl	bone
33	chr4:55102600-55103800	Weak transcription	NHDF-Ad	bronchial
34	chr4:55102600-55106200	Enhancers	Ovary	ovary
35	chr4:55102800-55103000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr4:55102800-55106200	Enhancers	Placenta	Placenta
37	chr4:55102800-55109000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr4:55103000-55103200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr4:55103000-55103400	Strong transcription	Cortex derived primary cultured neurospheres	brain
40	chr4:55103000-55103400	Enhancers	Fetal Lung	lung
41	chr4:55103200-55103600	Genic enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr4:55103200-55103800	Genic enhancers	Fetal Stomach	stomach
43	chr4:55103400-55103600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr4:55103400-55103600	Weak transcription	Fetal Lung	lung
45	chr4:55103400-55104200	Genic enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr4:55103400-55105000	Strong transcription	NHLF	lung
47	chr4:55103400-55107000	ZNF genes & repeats	Cortex derived primary cultured neurospheres	brain
48	chr4:55103400-55110000	ZNF genes & repeats	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr4:55103600-55103800	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr4:55103600-55103800	Enhancers	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links